Efficacy and Safety of Avatrombopag in Combination with Immunosuppressive Therapy in Treatment-Naive and Relapsed/Refractory Severe Aplastic Anaemia-the Diaamond-Ava-First and Diaamond-Ava-Next Bayesian Optimal Phase II Trials

Zoe McQuilten; Lucy C Fox; Vanessa Fox; Stephane Heritier; Tracey J Batt; Piers Blombery; Jennifer Curnow; Alisa Higgins; Devendra Hiwase; Robin J Filshie; Frank Firkin; Paul Lacaze; Kylie D. Mason; Tony Mills; Sushrut Patil; Dominic Pepperell; William S Stevenson; Jeffrey Szer; Neil Waters; Kate Wilson; Stephen B.N. Ting; Erica M. Wood

doi:10.1182/blood-2022-168963

Efficacy and Safety of Avatrombopag in Combination with Immunosuppressive Therapy in Treatment-Naive and Relapsed/Refractory Severe Aplastic Anaemia-the Diaamond-Ava-First and Diaamond-Ava-Next Bayesian Optimal Phase II Trials

Zoe McQuilten, Lucy C Fox, Vanessa Fox, Stephane Heritier, Tracey J Batt, Piers Blombery, Jennifer Curnow, Alisa Higgins, Devendra Hiwase, Robin J Filshie, Frank Firkin, Paul Lacaze, Kylie D. Mason, Tony Mills, Sushrut Patil, Dominic Pepperell, William S Stevenson, Jeffrey Szer, Neil Waters, Kate WilsonStephen B.N. Ting, Erica M. Wood

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	2931-2932
Number of pages	2
Journal	Blood
Volume	140
Issue number	Supplement 1
DOIs	https://doi.org/10.1182/blood-2022-168963
Publication status	Published - 15 Nov 2022
Event	Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) 2022 - New Orleans, United States of America Duration: 10 Dec 2022 → 13 Dec 2022 Conference number: 64th https://www.sciencedirect.com/journal/blood/vol/140/suppl/S1 (Meeting abstract published in Supplementary Issue of Blood) https://www.hematology.org/meetings/annual-meeting

Access to Document

10.1182/blood-2022-168963

Cite this

McQuilten, Z., Fox, L. C., Fox, V., Heritier, S., Batt, T. J., Blombery, P., Curnow, J., Higgins, A., Hiwase, D., Filshie, R. J., Firkin, F., Lacaze, P., Mason, K. D., Mills, T., Patil, S., Pepperell, D., Stevenson, W. S., Szer, J., Waters, N., ... Wood, E. M. (2022). Efficacy and Safety of Avatrombopag in Combination with Immunosuppressive Therapy in Treatment-Naive and Relapsed/Refractory Severe Aplastic Anaemia-the Diaamond-Ava-First and Diaamond-Ava-Next Bayesian Optimal Phase II Trials. Blood, 140(Supplement 1), 2931-2932. https://doi.org/10.1182/blood-2022-168963

@article{5995438a3b10404f84ec37381ec29e98,

title = "Efficacy and Safety of Avatrombopag in Combination with Immunosuppressive Therapy in Treatment-Naive and Relapsed/Refractory Severe Aplastic Anaemia-the Diaamond-Ava-First and Diaamond-Ava-Next Bayesian Optimal Phase II Trials",

author = "Zoe McQuilten and Fox, {Lucy C} and Vanessa Fox and Stephane Heritier and Batt, {Tracey J} and Piers Blombery and Jennifer Curnow and Alisa Higgins and Devendra Hiwase and Filshie, {Robin J} and Frank Firkin and Paul Lacaze and Mason, {Kylie D.} and Tony Mills and Sushrut Patil and Dominic Pepperell and Stevenson, {William S} and Jeffrey Szer and Neil Waters and Kate Wilson and Ting, {Stephen B.N.} and Wood, {Erica M.}",

year = "2022",

month = nov,

day = "15",

doi = "10.1182/blood-2022-168963",

language = "English",

volume = "140",

pages = "2931--2932",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "Supplement 1",

note = "Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) 2022, ASH 2022 ; Conference date: 10-12-2022 Through 13-12-2022",

url = "https://www.sciencedirect.com/journal/blood/vol/140/suppl/S1, https://www.hematology.org/meetings/annual-meeting",

}

McQuilten, Z , Fox, LC, Fox, V, Heritier, S, Batt, TJ, Blombery, P, Curnow, J, Higgins, A, Hiwase, D, Filshie, RJ, Firkin, F, Lacaze, P, Mason, KD, Mills, T, Patil, S, Pepperell, D, Stevenson, WS, Szer, J, Waters, N, Wilson, K, Ting, SBN & Wood, EM 2022, 'Efficacy and Safety of Avatrombopag in Combination with Immunosuppressive Therapy in Treatment-Naive and Relapsed/Refractory Severe Aplastic Anaemia-the Diaamond-Ava-First and Diaamond-Ava-Next Bayesian Optimal Phase II Trials', Blood, vol. 140, no. Supplement 1, pp. 2931-2932. https://doi.org/10.1182/blood-2022-168963

Efficacy and Safety of Avatrombopag in Combination with Immunosuppressive Therapy in Treatment-Naive and Relapsed/Refractory Severe Aplastic Anaemia-the Diaamond-Ava-First and Diaamond-Ava-Next Bayesian Optimal Phase II Trials. / McQuilten, Zoe ; Fox, Lucy C; Fox, Vanessa et al.
In: Blood, Vol. 140, No. Supplement 1, 15.11.2022, p. 2931-2932.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Efficacy and Safety of Avatrombopag in Combination with Immunosuppressive Therapy in Treatment-Naive and Relapsed/Refractory Severe Aplastic Anaemia-the Diaamond-Ava-First and Diaamond-Ava-Next Bayesian Optimal Phase II Trials

AU - McQuilten, Zoe

AU - Fox, Lucy C

AU - Fox, Vanessa

AU - Heritier, Stephane

AU - Batt, Tracey J

AU - Blombery, Piers

AU - Curnow, Jennifer

AU - Higgins, Alisa

AU - Hiwase, Devendra

AU - Filshie, Robin J

AU - Firkin, Frank

AU - Lacaze, Paul

AU - Mason, Kylie D.

AU - Mills, Tony

AU - Patil, Sushrut

AU - Pepperell, Dominic

AU - Stevenson, William S

AU - Szer, Jeffrey

AU - Waters, Neil

AU - Wilson, Kate

AU - Ting, Stephen B.N.

AU - Wood, Erica M.

N1 - Conference code: 64th

PY - 2022/11/15

Y1 - 2022/11/15

U2 - 10.1182/blood-2022-168963

DO - 10.1182/blood-2022-168963

M3 - Meeting Abstract

SN - 0006-4971

VL - 140

SP - 2931

EP - 2932

JO - Blood

JF - Blood

IS - Supplement 1

T2 - Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) 2022

Y2 - 10 December 2022 through 13 December 2022

ER -

McQuilten Z , Fox LC, Fox V, Heritier S, Batt TJ, Blombery P et al. Efficacy and Safety of Avatrombopag in Combination with Immunosuppressive Therapy in Treatment-Naive and Relapsed/Refractory Severe Aplastic Anaemia-the Diaamond-Ava-First and Diaamond-Ava-Next Bayesian Optimal Phase II Trials. Blood. 2022 Nov 15;140(Supplement 1):2931-2932. doi: 10.1182/blood-2022-168963